EP Patent
EP3349735A4 — Multi-phase release of sports nutrition and energy drink compositions utilizing lipid particulates
Assigned to Corr-Jensen Inc · Expires 2019-05-15 · 7y expired
What this patent protects
Patent listed against Topamax.
Drugs covered by this patent
- Topamax (topiramate) · Janssen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.